National
Military Laboratory is extinguished and gives place to LM – National Medicine Laboratory
O Decree-Law No. 13/2021, of 10 February, gives an account of the extinction of the Military Laboratory of Chemicals and Pharmaceuticals (LMPQF) to give rise to the creation of the National Medicines Laboratory (LM). This new laboratory, integrated into the Army, could produce cannabis-based drugs, but the details are not yet known.
Currently, the LMPQF already produces, among others, orphan drugs for rare diseases and some drugs abandoned by the pharmaceutical industry, activates production lines to respond to emergencies or drug shortages and is the producer of methadone, which is used in substitution programs dependencies or antidotes to military and civilian practice.
The creation of the LM is part of a commitment to national production in the medicine sector, guaranteeing the strategic production of essential medicines, supplying the needs not covered by the pharmaceutical industry and also allowing for an increase in economic development. It is also part of the promotion of the national scientific and technological system in the medicine sector, encouraging public research and therapeutic innovation.
The designation «LM – Laboratório Nacional do Medicamento» aims to continue the «LM» brand, maintaining its value, as it is a distinctive, identifying and representative trait of quality for more than 100 years of work in the pharmaceutical field.
Military Laboratory, an independent centennial institution, merged with the Army in 2019
Decree-Law no. 102/2019, of August 6, defined the terms of the merger of the Military Laboratory of Chemicals and Pharmaceuticals (LMPQF) in the Army, as an organ of support to more than one branch, removing its legal personality, and approved the rules of its organization and operation.
In the aforementioned decree-law, the main mission of the LMPQF, a century-old institution, continued to be of a military nature, providing logistical support in the areas of medicine and sanitary material to the Armed Forces, which includes the national forces deployed. Furthermore, its links with bodies outside the Army were reinforced, in particular with other branches of the Armed Forces and with the General Staff of the Armed Forces, and its relations with the Ministry of Health were strengthened, since cooperation between the areas of health and national defense justifies continuous articulation at the policy level, as well as coordination between organizations and services, creating synergies aimed at better pursuit of the public interest.
A Law No. 2 / 2020, of 31 March, which approved the State Budget for 2020, in its current wording, established the creation of the National Medicines Laboratory (LM), part of the Army's organizational structure, endowed with administrative and financial autonomy and its own assets, and which succeeds the LMPQF in all of its rights and obligations.
The definition of strategic guidelines and the setting of objectives for the LM, as well as the monitoring of its execution, are articulated between the members of the Government responsible for the areas of national defense and health, in cooperation with the member of the Government responsible for the area of science and technology. As a State laboratory, the legal regime in force for institutions dedicated to scientific research and technological development applies to LM.
In fact, the LM, as a State laboratory, has the mission of contributing to the development of research and production of medicines, medical devices and other health products, carrying out these activities in line with what is established in the national and community legislative and regulatory framework. applicable to these products.
At the military and operational level, the LM has a specific mission to support the Armed Forces, in the area of technical-military cooperation, in the development of health actions, in carrying out clinical analyses, and, in the assistance area, in pharmaceutical support to the military and to the disabled in the Armed Forces.
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.
I can be contacted by email at joao.costa@cannareporter.eu
Thailand has found a solution where European countries still see a problem.
Reading Time: 13 minutes On my second trip to Thailand, I was once again pleasantly surprised. After visiting several...
The Royal Thai Embassy in Tokyo promotes "Adapting International Hemp to Japan's New Regulations"
Reading Time: 3 minutes The International Business Meeting “Adapting the International Market...” will take place tomorrow, November 13, 2025.
Portugal: Infarmed updates lists and removes licenses from two more medicinal cannabis companies.
Reading Time: 2 minutes. Infarmed has updated the public list of entities licensed for activities with medicinal cannabis in Portugal. The...
Portocanna strengthens its Hexacan portfolio with a new sublingual solution containing 20% THC.
Reading Time: 2 minutes. The Portuguese company Portocanna announced the launch of Hexacan® Hexa 01 Cannabis Oil Extract THC 20%,...
Cypress Hill confirmed for Rock in Rio Lisboa 2026
Reading Time: 2 minutes. The legendary American band Cypress Hill, whose hits "Insane in the Brain" and "Hits from the Bong"...
USA: Green Thumb Industries workers secure collective agreement after 45-day strike.
Reading Time: < 1 minute Workers at Green Thumb Industries, one of the largest multi-state cannabis companies in the United States...
Switzerland: Pacrim takes control of Medropharm and prepares for a new phase of expansion in medicinal cannabis.
Reading Time: 2 minutes. Pacrim has acquired two-thirds of the Swiss company Medropharm, thus gaining control of the company and its operations.
South Africa: Researchers discover rare phenolic compounds in cannabis leaves.
Reading Time: 4 minutes. Researchers at Stellenbosch University in South Africa have discovered that flavoalkaloids are produced in the leaves of the plant...
Covilhã – Dismantling of two cannabis greenhouses
Reading Time: < 1 minute The Castelo Branco Territorial Command, through the Criminal Investigation Unit (NIC) of Covilhã, in...
Tokyo will host the Japan International Hemp Expo on November 14th and 15th, 2025.
Reading Time: 4 minutes. For the first time since the legal reform, Japan opens its doors to the global hemp industry...
